My SciELO
Services on Demand
Article
Indicators
- Cited by SciELO
Related links
- Similars in SciELO
Share
Revista Cubana de Pediatría
On-line version ISSN 1561-3119
Abstract
PEREZ RODRIGUEZ, Antonio and DICKINSON MENESES, Félix. Resultados del Programa Nacional de Inmunización Antimeningocócica BC en menores de 1 año en Cuba. Rev Cubana Pediatr [online]. 1998, vol.70, n.3, pp. 133-140. ISSN 1561-3119.
The meningococcal disease (MD) is currently an important health problem all around the world. The VA-MENGOC-BC vaccin has been used in Cuba since 1991, in children under 1 year of age, through the National Immunization Program (NIP), and its results were assessed in this study. A descriptive study was carried out on morbidity and mortality due to MD, and in concordance with the vaccine backgrounds of 237 cases diagnosed between January 1st., 1991, and December 31st., 1996; the vaccine effectiveness was also estimated. Among the most important results there is the MD rate in this age group, which has decreased from 49,9 to 13/100 000 inhabitants, while the vaccine coverage has increased over the 95 % to reach a vaccine effectiveness over the 90 %. The major incidence at 3 months of age was displaced, with greater frequency in non-vaccinated patients. The general mortality was of 15,2 %. It was concluded that the use of VA-MENGOC-BC as a part of the NIP, decreased the morbidity and mortality due to the meningococcal disease in children under 1 year of age.
Keywords : BACTERIAL VACCINES [therapeutic use]; NEISSERIA MENINGITIDIS [immunology]; MENINGOCOCCAL INFECTIONS [prevention and control]; IMMUNIZATION PROGRAMS; EVALUATION; CUBA.